News, Analysis & Insights on Nutrition, Supplements, and Health
The Food and Drug Administration (FDA) has told US Senators Dick Durbin and Richard Blumenthal that is reviewing the safety of energy drinks and may take regulatory action if it finds a health risk.
Swiss biotech firm Evolva has bought failing Fluxome’s, yeast-derived resveratrol business for about €550,000 in cash and shares, but says it has no interest in the remaining omega-3 business being sold by sealed auction.
USANA Health Sciences has taken a conservative approach to new product development, making it a company lean on products but long on trust, says Brian Dixon, PhD, executive director of new product development.
A strike at the ports of Los Angeles and Long Beach is interrupting shipments of raw materials and is creating a “fulfillment panic” in the herbal industry, according to a leading botanical supplier.
The evidence supporting the heart health benefits of omega-3 fatty acids is strong, despite ‘less conclusive’ recent studies, says a new review from the Linus Pauling Institute at Oregon State University.
Exposing healthy people to modified pathogens in a controlled clinical trial setting could be an exciting new way for industry to overcome the challenges of health claim substantiation, says Nizo Food Research expert.